Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

The onset of checkpoint inhibition revolutionized the treatment of cancer. However, studies from the last decade suggested that the sole enhancement of T cell functionality might not suffice to fight malignancies in all individuals. Dendritic cells (DCs) are not only part of the innate immune system...

Descripción completa

Detalles Bibliográficos
Autores principales: Amon, Lukas, Hatscher, Lukas, Heger, Lukas, Dudziak, Diana, Lehmann, Christian H. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408110/
https://www.ncbi.nlm.nih.gov/pubmed/32674488
http://dx.doi.org/10.3390/pharmaceutics12070663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408110/
https://www.ncbi.nlm.nih.gov/pubmed/32674488
http://dx.doi.org/10.3390/pharmaceutics12070663

Ejemplares similares